About Clinion

AI is used by the award-winning eClinical platform Clinion to expedite and simplify clinical trials. Leading international clinical trial provider Clinion is well-known for its multi-award winning solutions that promote quality and innovation in the clinical research industry. They use state-of-the-art technology, such as GenAI and AI/ML, to speed up clinical studies and improve results. Pharmaceutical, biotechnology, and medical device businesses can run clinical trials more successfully and efficiently thanks to their unmatched knowledge. EDC, RTSM, CTMS, eCOA, document automation, eTMF, and safety technologies are all included in the Clinion platform. The platform from Clinion employs cutting-edge generative AI, AI, and ML technologies to shorten trial durations, lower costs, and increase compliance. Clinion is made to be easy to use, even by those with little experience with complex software. A study’s protocol can be created in three steps with Clinion’s eProtocol Automation tool. According to Medhealth Review, Clinion is the leading provider of clinical trial management solutions for 2023. In the Fall 2023 G2 Ratings, Clinion also received the High Performer Mid-Market Badge. Clinion offers a unified, integrated, cloud-based eClinical platform that includes EDC, ePRO, RTSM, CTMS, CSR Automation, and decentralized trial solutions. Rapidly expanding worldwide Clinion is a technology business that is transforming the healthcare industry by combining agility and scalability to gain a competitive edge. Clinion uses its in-depth subject expertise to dismantle silos, simplify digital complexity, and expedite the launch of new projects. Utilizing its platform and technological capabilities, Clinion offers comprehensive, complete clinical trial solutions. Clinion’s cutting-edge technology reduces risk and revolutionizes clinical trial management by assisting businesses in managing the patient journey in a more organic and intuitive way and the data journey in a more direct and objective manner—even in real-world settings. More than sixty people work with Clinion in our domestic and foreign offices in Germany, the UK, and India. The decentralized trial platform and Clinion eClinical offer a cost-effective competitive edge along with timely project delivery.